Suchergebnisse - "Gavrila, Elena"

PubPharm (9)

1

Study protocol : phase II study to evaluate the effect of cetuximab monotherapy after immunotherapy with PD-1 inhibitors in patients with head and neck squamous cell cancer

enthalten in: Therapeutic advances in medical oncology | 2024

von Burcher, K. | Bloomer, C. | Gavrila, E. | +14

2

Exceptional response to cetuximab monotherapy after failure of immunotherapy with a checkpoint inhibitor in a patient with metastatic head and neck squamous cell cancer : case report and review of the literature

enthalten in: Therapeutic advances in medical oncology | 2023

von Bloomer, C. | Gavrila, E. | Burcher, K. | +10

3

In Reply : TP53 Alteration Status and Tumor Mutational Burden Score: Prevalence and Prognosis in Head and Neck Squamous Cell Carcinoma

enthalten in: The oncologist | 2022

von Burcher, K. | Wilson, H. | Gavrila, E. | +4

CommentOn: Oncologist. 2021 Feb;26(2):e279-e289. - PMID 33098199

4

AKT mutant allele-specific activation dictates pharmacologic sensitivities

enthalten in: Nature communications | 2022

von Shrestha Bhattarai, T. | Shamu, T. | Gorelick, A. | +16

5

Serendipitous synergism - an exceptional response to treatment with pembrolizumab in the course of a natural immunovirotherapy : a case report and review of the literature

enthalten in: Therapeutic advances in medical oncology | 2022

von Khoury, L. | Burcher, K. | Ng, R. | +10

6

Relationship between Tumor Mutational Burden, PD-L1, Patient Characteristics, and Response to Immune Checkpoint Inhibitors in Head and Neck Squamous Cell Carcinoma

enthalten in: Cancers | 2021

von Burcher, K. | Lantz, J. | Gavrila, E. | +14

7

Leveraging Systematic Functional Analysis to Benchmark an In Silico Framework Distinguishes Driver from Passenger MEK Mutants in Cancer

enthalten in: Cancer research | 2020

von Hanrahan, A. | Sylvester, B. | Chang, M. | +26

CommentIn: Cancer Res. 2020 Oct 1;80(19):4042-4043. - PMID 33008803

8

Efficacy and Determinants of Response to HER Kinase Inhibition in HER2-Mutant Metastatic Breast Cancer

enthalten in: Cancer discovery | 2020

von Smyth, L. | Piha-Paul, S. | Won, H. | +44

9

Altered Nuclear Export Signal Recognition as a Driver of Oncogenesis

enthalten in: Cancer discovery | 2019

von Taylor, J. | Sendino, M. | Gorelick, A. | +24

CommentIn: Nat Rev Cancer. 2019 Oct;19(10):542-543. - PMID 31439948

1
[1]